Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Increased Intracranial Pressure l: Introduction

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...

Increased Intracranial Pressure ll: Pathophysiology

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cluster Analysis of Migraine-Associated Symptoms (CAMS) across the lifespan: a cross-sectional study.

BMC neurology·2026

Same author

Treatment outcomes in new daily persistent headache in children and adolescents.

Cephalalgia : an international journal of headache·2026

Same author

Patient reported trigger, not the speed of transition to continuous headache, is associated with headache-related disability in children: Results of a cross-sectional clinic-based study.

Cephalalgia : an international journal of headache·2026

Same author

Migraine-associated symptoms change with improvement in youth with migraine: A cohort study.

Cephalalgia reports·2026

Same author

Post-Traumatic Headache in Children and Genetic Risk of Migraine: An Observational Cohort Study.

Neurology. Genetics·2026

Same author

Headache-associated photophobia is more prevalent during winter: A cross-sectional study from a pediatric headache registry.

Headache·2026

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Recent developments in pediatric headache.

Andrew D Hershey¹

¹Department of Pediatrics, Division of Neurology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, College of Medicine, Cincinnati, Ohio 45229, USA. Andrew.Hershey@cchmc.org

Current Opinion in Neurology

|April 15, 2010

Summary

Recent findings in pediatric headache, particularly pediatric migraine, are improving our understanding of characteristics and treatment. Continued research is needed to fill knowledge gaps for better outcomes and prevent adult progression.

More Related Videos

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Related Experiment Videos

Last Updated: Jun 13, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Area of Science:

Neurology
Pediatrics
Headache Medicine

Background:

Pediatric headache is a common issue with significant impact on children and families.
Existing knowledge gaps hinder comprehensive understanding and effective treatment strategies.
Pediatric migraine is the most studied subtype, offering a foundation for broader insights.

Purpose of the Study:

To review recent advancements in pediatric headache research.
To highlight current understanding of headache characteristics, epidemiology, and comorbidities.
To discuss updates in the treatment of pediatric headache.

Main Methods:

Literature review of recent studies on pediatric headache.
Focus on characterized aspects of pediatric migraine.
Synthesis of findings on epidemiology, characteristics, and treatment.

Main Results:

Pediatric headache remains prevalent, with ongoing research revealing more about its features.
Increased recognition of headache characteristics and associated symptoms is enhancing clinical approaches.
Significant knowledge gaps persist in the epidemiology and treatment of pediatric headache.

Conclusions:

Improved understanding of pediatric headache characteristics and symptoms aids individualized treatment.
Enhanced diagnostic and therapeutic strategies can lead to better patient outcomes.
Early and effective management may reduce the likelihood of chronic headaches into adulthood.